Home » Topics » BioWorld Science

BioWorld Science
RSS

New preterm labor is drug safe with favorable pharmacokinetic profile

Aug. 31, 2018

PLIN2 is a putative tumor suppressor and prognostic marker of renal cell carcinoma

Aug. 31, 2018

Renin inhibitor TAK-272 developed at Takeda for heart failure

Aug. 31, 2018

Blincyto approved for use in pediatric patients with Ph- relapsed or refractory B-cell precursor ALL

Aug. 30, 2018

First patient dosed in phase II clinical trial in Duchenne muscular dystrophy

Aug. 30, 2018

Poxel acquires DRX-065 and portfolio of additional deuterated drug candidates

Aug. 30, 2018

Sophiris Bio announces update on phase IIb trial in localized prostate cancer

Aug. 30, 2018

Vertex and Genomics collaborate to advance discovery of precision medicines

Aug. 30, 2018

Lenvima capsules approved for first-line treatment of HCC in South Korea

Aug. 30, 2018

Positive XEN-1101 pharmacodynamic data from Xenon's phase Ib TMS study

Aug. 30, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...